The Positron Emission Tomography Market size was estimated USD 2.5 billion in 2022 and is expected to reach USD 3.93 billion by 2030 at a CAGR of 6.7% during the forecast period of 2023-2030.
The increasing need for PET analysis in radiopharmaceuticals, as well as the incorporation of X-ray tomography (CT) into PET, are some of the reasons driving market expansion. According to the World Nuclear Association's April 2022 report, over 40 million nuclear medicine treatments are conducted each year, with radioisotope demand increasing by up to 5% annually. Over 10,000 hospitals worldwide employ radioisotopes in medicine, with approximately 90% of treatments being diagnostic. According to the same source, the frequency of diagnostic nuclear medicine is 1.9% per year in industrialized countries (approximately one-quarter of the total population), and the frequency of radioisotope therapy is roughly one-tenth. Furthermore, nearly 20 million nuclear medicine-related treatments are conducted each year in the United States, and approximately 10 million in Europe.million.
.png)
In Australia, around 560,000 treatments are performed each year, with 470,000 of these procedures utilizing reactor isotopes. The use of radiopharmaceuticals in diagnosis is increasing at a rate of more than 10% each year. PET uses small amounts of radioactive materials known as radiotracers or radiopharmaceuticals, a specific camera, and a computer to analyze organ and tissue functions. As a result, the increase in radiopharmaceutical analysis is expected to promote market growth throughout the projection period. Technological innovations such as the advent of Time of Flight (TOF) imaging systems and the increasing popularity of hybrid imaging systems all contribute to the growth of the nuclear imaging industry. For example, in June 2022, University of Oxford researchers created three DL-TOF models (based on U-Net convolutional neural networks) that transform non-TOF PET data into matching TOF-like pictures. To balance contrast enhancement and noise reduction, the model used different levels of TOF strength (low, medium, and high). As a result, such PET advancements are projected to promote market growth over the forecast period. Furthermore, market participants are focusing on collaboration methods to increase their product portfolios.
DRIVERS
Multimodal PET imaging systems are becoming more popular.
The use of hybrid imaging modalities in nuclear imaging is a growing trend in the diagnostic imaging business. The integration of PET/CT equipment has greatly improved imaging capabilities and cancer diagnosis. The advent of a high-precision, low-radiation-dose PET/CT machine with great prognostic ability based on value has resulted in a rise in PET/CT equipment adoption by hospitals and diagnostic centers.
RESTRAIN
Capital and operational costs are both high.
Because of the high expense of obtaining and operating PET scanners, their availability and use in healthcare settings may be limited. PET scanners have high initial capital expenses, ranging from several hundred thousand to over a million dollars, which can be a substantial obstacle for hospitals and medical centers with limited resources. Furthermore, PET scanners necessitate continuing maintenance, calibration, and repair, as well as trained staff to operate and interpret the results, resulting in large ongoing costs that mount over time. Because of these issues, PET scanners are an expensive investment for many healthcare providers. The high cost of PET scanners can make them prohibitively expensive for smaller hospitals and medical facilities in rural locations to purchase and run.
OPPORTUNITY
Increase in the use of PET for the identification of breast cancer.
CHALLENGES
Alternative imaging technologies are available.
International Cooperation and Trade International commerce partnerships and collaborations can be influenced by geopolitical concerns. This could have an impact on the exchange of PET technology, isotopes, and expertise between countries. Clinical Applications: Due to logistical problems, safety concerns, and adjustments in healthcare priorities, utilization of healthcare services, particularly modern imaging technology like PET, may be hindered in conflict-affected areas. Conflict and geopolitical instability may reduce a region's desirability for medical tourism, particularly access to modern medical imaging services. Remote Consultations and Telemedicine If physical access to healthcare facilities is restricted owing to conflict-related causes, there may be a greater emphasis on telemedicine and remote consultations, which may affect the use of certain medical imaging technologies.
GSMSG first assembled a 10-person combat surgery team, which reached Ukraine nine days after Russia invaded. Their mission was to train any interested and capable Ukrainian citizen in combat casualty care, to provide combat trauma care training and surgical support to the civilian Ukrainian medical system, and to provide combat care training to Ukrainian military personnel and military physicians. GSMSG rotated additional teams of surgeons with experience in trauma, surgical critical care, burn, plastics, orthopaedics, vascular, and neurosurgery. GSMSG rotated additional teams of surgeons with experience in trauma, surgical critical care, burn, plastics, orthopaedics, vascular, and neurosurgery. GSMSG also created a collaboration with the Ukrainian Armed Forces, Ukrainian Special Operations Forces (UKRSOF), and Ukrainian Special Surgical Groups, with the support of the Ukrainian Ministry of Defense and Ministry of Health, to offer damage control surgery as close to the scene as possible. as 0.5 kilometers from active action with Russian forces. Since their arrival in Ukraine, GSMSG team members have trained over 20,000 Ukrainian civilians and military personnel. They have also provided surgical support to over 300 patients, some of whom are within 10 kilometers of the battle lines.
IMPACT OF ONGOING RECESSION
Capital Expenditures Deferred Due to budgetary restrictions, healthcare organizations may postpone or cancel capital investments, which could include the purchase of expensive medical imaging equipment such as PET scanners. Patient Volume Reduction Recessions can result in lower patient numbers as people postpone or avoid non-urgent medical procedures, such as PET scans. This could have an effect on the demand for PET services. Research, development, and innovation Economic downturns can lead to a reduction in R&D investments. This could hinder technological advancement and the launch of new PET scanner models or software upgrades.
By Product
PETICT Systems
Low Slice Scanners
Medium Slice Scanners
High Slice Scanners
PET/MRI Systems
By Application
Oncology Applications
Neurological Applications
Cardiovascular Applications
Other Applications
By End User
Hospital & Surgical Centers
Diagnostic & Imaging Clinics
Ambulatory Care Centers
Other End Users
.png)
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
The North American region had the highest market share by region, accounting for 42.2% of the global market for Positron Emission Tomography (PET) scanners. Because of the region's high need for precise diagnosis and technological developments in PET technology, North America dominates the positron emission tomography sector. According to the OECD, 6 PET scans were performed per 1000 people in 2018, with that figure predicted to more than double in 2019. As a result of rising demand for PET scans, the market in this area expanded. The Asia-Pacific region, led by Australia, China, India, and South Korea, is predicted to be the fastest-growing positron emission tomography market, with a market value of roughly US$88.9 million by 2027.
The major key players are Positron Corporation, Cellsight Technologies, Reflexion, Clarity Pharmaceuticals, PETsys Electronics SA, Blue Earth Diagnostics Limited, Qubiotech Health Intelligence S.L, Advanced Accelerator Applications, Lily, Agfa-Gevaert Group, CMR Naviscan and others.
United Imaging: In February 2023, United Imaging, a renowned global leader in sophisticated medical imaging and radiation technology, was a Platinum partner at Arab Health 2023, which took place from January 30 to February 2 in Dubai, UAE. They displayed a wide range of cutting-edge medical imaging devices, including the HD TOF PET/MR uPMR 790, which can produce high-quality images; the uCT 960+, a 16cm detector/640 slice CT scanner that is the fastest cardiac CT scanner in the world; the uMI 780, an ultra-fast high-resolution digital PET/CT scanner; the uMR 680, a 1.5T Wide Bore MRI System with "3T-like" performance.
| Report Attributes | Details |
| Market Size in 2022 | US$ 2.5 Bn |
| Market Size by 2030 | US$ 3.93 Bn |
| CAGR | CAGR of 6.7% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (PETICT Systems, Low Slice Scanners, Medium Slice Scanners, High Slice Scanners, PET/MRI Systems) • By Application (Oncology Applications, Neurological Applications, Cardiovascular Applications, Other Applications) • By End User (Hospital & Surgical Centers, Diagnostic & Imaging Clinics, Ambulatory Care) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Positron Corporation, Cellsight Technologies, Reflexion, Clarity Pharmaceuticals, PETsys Electronics SA, Blue Earth Diagnostics Limited, Qubiotech Health Intelligence S.L, Advanced Accelerator Applications, Lily, Agfa-Gevaert Group, CMR Naviscan |
| Key Drivers | • Multimodal PET imaging systems are becoming more popular. |
| Market Restraints | • Capital and operational costs are both high. |
Ans: The Positron Emission Tomography Market is expected to grow at 6.7% CAGR from 2023 to 2030.
Ans: According to our analysis, the Positron Emission Tomography Market is anticipated to reach USD 3.93 billion By 2030.
Ans: The leading participants in the,Positron Corporation, Cellsight Technologies, Reflexion, Clarity Pharmaceuticals, PETsys Electronics SA, Blue Earth Diagnostics Limited.
Ans: Increased cancer cases and expanding PET applications are the primary drivers of market growth.
Ans: Yes, you may request customization based on your company's needs.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Positron Emission Tomography Market, By Product
8.1 PETICT Systems
8.2 Low Slice Scanners
8.3 Medium Slice Scanners
8.4 High Slice Scanners
8.5 PET/MRI Systems
9. Positron Emission Tomography Market, By Application
9.1 Oncology Applications
9.2 Neurological Applications
9.3 Cardiovascular Applications
9.4 Other Applications
10. Positron Emission Tomography Market, By End User
10.1 Hospital & Surgical Centers
10.2 Diagnostic & Imaging Clinics
10.3 Ambulatory Care Centers
10.4 Other End Users
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Positron Emission Tomography Market by country
11.2.2North America Positron Emission Tomography Market by Product
11.2.3 North America Positron Emission Tomography Market by Application
11.2.4 North America Positron Emission Tomography Market by End-user
11.2.5 USA
11.2.5.1 USA Positron Emission Tomography Market by Product
11.2.5.2 USA Positron Emission Tomography Market by Application
11.2.5.3 USA Positron Emission Tomography Market by End-user
11.2.6 Canada
11.2.6.1 Canada Positron Emission Tomography Market by Product
11.2.6.2 Canada Positron Emission Tomography Market by Application
11.2.6.3 Canada Positron Emission Tomography Market by End-user
11.2.7 Mexico
11.2.7.1 Mexico Positron Emission Tomography Market by Product
11.2.7.2 Mexico Positron Emission Tomography Market by Application
11.2.7.3 Mexico Positron Emission Tomography Market by End-user
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Positron Emission Tomography Market by country
11.3.1.2 Eastern Europe Positron Emission Tomography Market by Product
11.3.1.3 Eastern Europe Positron Emission Tomography Market by Application
11.3.1.4 Eastern Europe Positron Emission Tomography Market by End-user
11.3.1.5 Poland
11.3.1.5.1 Poland Positron Emission Tomography Market by Product
11.3.1.5.2 Poland Positron Emission Tomography Market by Application
11.3.1.5.3 Poland Positron Emission Tomography Market by End-user
11.3.1.6 Romania
11.3.1.6.1 Romania Positron Emission Tomography Market by Product
11.3.1.6.2 Romania Positron Emission Tomography Market by Application
11.3.1.6.4 Romania Positron Emission Tomography Market by End-user
11.3.1.7 Turkey
11.3.1.7.1 Turkey Positron Emission Tomography Market by Product
11.3.1.7.2 Turkey Positron Emission Tomography Market by Application
11.3.1.7.3 Turkey Positron Emission Tomography Market by End-user
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Positron Emission Tomography Market by Product
11.3.1.8.2 Rest of Eastern Europe Positron Emission Tomography Market by Application
11.3.1.8.3 Rest of Eastern Europe Positron Emission Tomography Market by End-user
11.3.2 Western Europe
11.3.2.1 Western Europe Positron Emission Tomography Market by Product
11.3.2.2 Western Europe Positron Emission Tomography Market by Application
11.3.2.3 Western Europe Positron Emission Tomography Market by End-user
11.3.2.4 Germany
11.3.2.4.1 Germany Positron Emission Tomography Market by Product
11.3.2.4.2 Germany Positron Emission Tomography Market by Application
11.3.2.4.3 Germany Positron Emission Tomography Market by End-user
11.3.2.5 France
11.3.2.5.1 France Positron Emission Tomography Market by Product
11.3.2.5.2 France Positron Emission Tomography Market by Application
11.3.2.5.3 France Positron Emission Tomography Market by End-user
11.3.2.6 UK
11.3.2.6.1 UK Positron Emission Tomography Market by Product
11.3.2.6.2 UK Positron Emission Tomography Market by Application
11.3.2.6.3 UK Positron Emission Tomography Market by End-user
11.3.2.7 Italy
11.3.2.7.1 Italy Positron Emission Tomography Market by Product
11.3.2.7.2 Italy Positron Emission Tomography Market by Application
11.3.2.7.3 Italy Positron Emission Tomography Market by End-user
11.3.2.8 Spain
11.3.2.8.1 Spain Positron Emission Tomography Market by Product
11.3.2.8.2 Spain Positron Emission Tomography Market by Application
11.3.2.8.3 Spain Positron Emission Tomography Market by End-user
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Positron Emission Tomography Market by Product
11.3.2.9.2 Netherlands Positron Emission Tomography Market by Application
11.3.2.9.3 Netherlands Positron Emission Tomography Market by End-user
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Positron Emission Tomography Market by Product
11.3.2.10.2 Switzerland Positron Emission Tomography Market by Application
11.3.2.10.3 Switzerland Positron Emission Tomography Market by End-user
11.3.2.11.1 Austria
11.3.2.11.2 Austria Positron Emission Tomography Market by Product
11.3.2.11.3 Austria Positron Emission Tomography Market by Application
11.3.2.11.4 Austria Positron Emission Tomography Market by End-user
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Positron Emission Tomography Market by Product
11.3.2.12.2 Rest of Western Europe Positron Emission Tomography Market by Application
11.3.2.12.3 Rest of Western Europe Positron Emission Tomography Market by End-user
11.4 Asia-Pacific
11.4.1 Asia-Pacific Positron Emission Tomography Market by country
11.4.2 Asia-Pacific Positron Emission Tomography Market by Product
11.4.3 Asia-Pacific Positron Emission Tomography Market by Application
11.4.4 Asia-Pacific Positron Emission Tomography Market by End-user
11.4.5 China
11.4.5.1 China Positron Emission Tomography Market by Product
11.4.5.2 China Positron Emission Tomography Market by Application
11.4.5.3 China Positron Emission Tomography Market End-user
11.4.6 India
11.4.6.1 India Positron Emission Tomography Market by Product
11.4.6.2 India Positron Emission Tomography Market by Application
11.4.6.3 India Positron Emission Tomography Market by End-user
11.4.7 Japan
11.4.7.1 Japan Positron Emission Tomography Market by Product
11.4.7.2 Japan Positron Emission Tomography Market by Application
11.4.7.3 Japan Positron Emission Tomography Market by End-user
11.4.8 South Korea
11.4.8.1 South Korea Positron Emission Tomography Market by Product
11.4.8.2 South Korea Positron Emission Tomography Market by Application
11.4.8.3 South Korea Positron Emission Tomography Market by End-user
11.4.9 Vietnam
11.4.9.1 Vietnam Positron Emission Tomography Market by Product
11.4.9.2 Vietnam Positron Emission Tomography Market by Application
11.4.9.3 Vietnam Positron Emission Tomography Market by End-user
11.4.10 Singapore
11.4.10.1 Singapore Positron Emission Tomography Market by Product
11.4.10.2 Singapore Positron Emission Tomography Market by Application
11.4.10.3 Singapore Positron Emission Tomography Market by End-user
11.4.11 Australia
11.4.11.1 Australia Positron Emission Tomography Market by Product
11.4.11.2 Australia Positron Emission Tomography Market by Application
11.4.11.3 Australia Positron Emission Tomography Market by End-user
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Positron Emission Tomography Market by Product
11.4.12.2 Rest of Asia-Pacific Positron Emission Tomography Market by Application
11.4.12.3 Rest of Asia-Pacific Positron Emission Tomography Market by End-user
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Positron Emission Tomography Market by country
11.5.1.2 Middle East Positron Emission Tomography Market by Product
11.5.1.3 Middle East Positron Emission Tomography Market by Application
11.5.1.4 Middle East Positron Emission Tomography Market by End-user
11.5.1.5 UAE
11.5.1.5.1 UAE Positron Emission Tomography Market by Product
11.5.1.5.2 UAE Positron Emission Tomography Market by Application
11.5.1.5.3 UAE Positron Emission Tomography Market by End-user
11.5.1.6 Egypt
11.5.1.6.1 Egypt Positron Emission Tomography Market by Product
11.5.1.6.2 Egypt Positron Emission Tomography Market by Application
11.5.1.6.3 Egypt Positron Emission Tomography Market by End-user
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Positron Emission Tomography Market by Product
11.5.1.7.2 Saudi Arabia Positron Emission Tomography Market by Application
11.5.1.7.3 Saudi Arabia Positron Emission Tomography Market by End-user
11.5.1.8 Qatar
11.5.1.8.1 Qatar Positron Emission Tomography Market by Product
11.5.1.8.2 Qatar Positron Emission Tomography Market by Application
11.5.1.8.3 Qatar Positron Emission Tomography Market by End-user
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Positron Emission Tomography Market by Product
11.5.1.9.2 Rest of Middle East Positron Emission Tomography Market by Application
11.5.1.9.3 Rest of Middle East Positron Emission Tomography Market by End-user
11.5.2 Africa
11.5.2.1 Africa Positron Emission Tomography Market by country
11.5.2.2 Africa Positron Emission Tomography Market by Product
11.5.2.3 Africa Positron Emission Tomography Market by Application
11.5.2.4 Africa Positron Emission Tomography Market by End-user
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Positron Emission Tomography Market by Product
11.5.2.5.2 Nigeria Positron Emission Tomography Market by Application
11.5.2.5.3 Nigeria Positron Emission Tomography Market by End-user
11.5.2.6 South Africa
11.5.2.6.1 South Africa Positron Emission Tomography Market by Product
11.5.2.6.2 South Africa Positron Emission Tomography Market by Application
11.5.2.6.3 South Africa Positron Emission Tomography Market by End-user
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Positron Emission Tomography Market by Product
11.5.2.7.2 Rest of Africa Positron Emission Tomography Market by Application
11.5.2.7.3 Rest of Africa Positron Emission Tomography Market by End-user
11.6 Latin America
11.6.1 Latin America Positron Emission Tomography Market by country
11.6.2 Latin America Positron Emission Tomography Market by Product
11.6.3 Latin America Positron Emission Tomography Market by Application
11.6.4 Latin America Positron Emission Tomography Market by End-user
11.6.5 Brazil
11.6.5.1 Brazil America Wheelchair by Product
11.6.5.2 Brazil America Wheelchair by Application
11.6.5.3 Brazil America Wheelchair by End-user
11.6.6 Argentina
11.6.6.1 Argentina America Wheelchair by Product
11.6.6.2 Argentina America Wheelchair by Application
11.6.6.3 Argentina America Wheelchair by End-user
11.6.7 Colombia
11.6.7.1 Colombia America Wheelchair by Product
11.6.7.2 Colombia America Wheelchair by Application
11.6.7.3 Colombia America Wheelchair by End-user
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Wheelchair by Product
11.6.8.2 Rest of Latin America Wheelchair by Application
11.6.8.3 Rest of Latin America Wheelchair by End-user
12 Company profile
12.1 Positron Corporation.
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Product/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Cellsight Technologies.
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Reflexion.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Clarity Pharmaceuticals.
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 PETsys Electronics SA.
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Blue Earth Diagnostics Limited.
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Qubiotech Health Intelligence S.L.
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Advanced Accelerator Applications.
12.8.2 Financials
12.8.3 Product/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Lily.
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Agfa-Gevaert Group.
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Venous Leg Ulcer (VLU) Treatment Market was valued USD 4.09 Billion by 2023 and expected to reach nearly USD 6.87 Billion by 2031, at CAGR 6.7% for the projected year 2024-2031.
The Biotechnology Reagents & Kits Market size was estimated USD 596.3 billion in 2022 and is expected to reach USD 1374.1 billion by 2030 at a CAGR of 11.0% during the forecast period of 2023-2030.
The Medical Terminology Software Market Size was valued at USD 1239.76 million in 2022, and is expected to reach USD 5547 million by 2030, and grow at a CAGR of 20.6% over the forecast period 2023-2030.
The Point of Care Lipid Test Market size was estimated USD 41.33 billion in 2023 and is expected to reach USD 69.96 billion by 2031 at a CAGR of 6.8% during the forecast period of 2024-2031.
The Inflammatory Bowel Disease Drugs Market size was valued at USD 21.15 Billion in 2023 and is expected to reach USD 27.65 Billion By 2031 and grow at a CAGR of 3.47% over the forecast period of 2024-2031.
The Chromatography Software Market Size was valued at USD 1.2 billion in 2023 and is expected to reach USD 2.8 billion by 2031 and grow at a CAGR of 11.4% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
